Werbung
Werbung

MBX

MBX logo

MBX Biosciences, Inc. Common Stock

31.69
USD
Gesponsert
+0.97
+3.15%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

31.80

+0.11
+0.36%

MBX Ergebnisberichte

Positives Überraschungsverhältnis

MBX übertreffen die 4 der letzten 5Schätzungen.

80%

Nächster Bericht

Datum des nächsten Berichts
17. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.66
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
+4.76%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
+40.43%

MBX Biosciences, Inc. Common Stock earnings per share and revenue

On 06. Nov. 2025, MBX reported earnings of -0.63 USD per share (EPS) for Q3 25, beating the estimate of -0.70 USD, resulting in a 10.09% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +9.71% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.66 USD, with revenue projected to reach -- USD, implying an increase of 4.76% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, MBX Biosciences, Inc. Common Stock reported EPS of -$0.63, beating estimates by 10.09%, and revenue of $0.00, 0% as expectations.
The stock price moved up 9.71%, changed from $22.55 before the earnings release to $24.74 the day after.
The next earning report is scheduled for 17. März 2026.
Based on 10 analysts, MBX Biosciences, Inc. Common Stock is expected to report EPS of -$0.66 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung